COVID-19 中度病例住院费用的决定因素。
Determinants of Hospitalization Costs among Moderate Cases of COVID-19.
机构信息
Yongjia County People's Hospital, China.
Sir Run Run Shaw Hospital, 56660Zhejiang University School of Medicine, China.
出版信息
Inquiry. 2022 Jan-Dec;59:469580211059483. doi: 10.1177/00469580211059483.
To estimate demographic predictors of medical expense in hospitalization of moderate COVID-19. From January to March 2020, a total of 39 patients were treated and recovered from COVID-19 in a tertiary medical center in East China. Detailed cost data were collected and we estimated the demographic predictors of both total hospital expense and daily hospital expense. The mean medical expense for treating hospitalized moderate COVID-19 cases was $1177.81. Every additional year in the patient's age corresponds to .9% more in total hospital expense (Coef. = 0.009, 95% CI 0.002-0.017, < 0.01). The difference in daily medical expense between age groups was not statistically significant. Hospitalization cost was significantly elevated among the older patients, and the age effect in cost was mainly driven by the longer length of stay in the hospital. From a cost-saving perspective, the elderly population might deserve priority consideration when COVID-19 vaccination programs are implemented.
目的
评估中度 COVID-19 住院患者医疗费用的人口学预测因素。方法：2020 年 1 月至 3 月，在华东地区的一家三级医疗机构共收治并治愈了 39 例 COVID-19 患者。收集了详细的费用数据，并估计了总住院费用和日住院费用的人口学预测因素。结果：治疗住院中度 COVID-19 患者的平均医疗费用为 1177.81 美元。患者年龄每增加 1 岁，总住院费用增加 0.9%（系数=0.009，95%CI 0.002-0.017，<0.01）。不同年龄组之间的日医疗费用差异无统计学意义。老年患者的住院费用明显升高，费用的年龄效应主要是由于住院时间延长所致。结论：从节省成本的角度来看，在实施 COVID-19 疫苗接种计划时，老年人群可能需要优先考虑。
Zotero 插件